292 related articles for article (PubMed ID: 30336525)
1. Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.
Sun C; Xu G; Lin J
Clin Lab; 2018 Oct; 64(10):1671-1678. PubMed ID: 30336525
[TBL] [Abstract][Full Text] [Related]
2. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
[TBL] [Abstract][Full Text] [Related]
3. Multicentric Castleman disease mimicking IgG4-related disease: A case report.
Izumi Y; Takeshita H; Moriwaki Y; Hisatomi K; Matsuda M; Yamashita N; Kawahara C; Shigemitsu Y; Iwanaga N; Kawakami A; Kurohama H; Niino D; Ito M; Migita K
Mod Rheumatol; 2017 Jan; 27(1):174-177. PubMed ID: 25528859
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic dilemma of IgG4-related primary localized cervical lymphadenopathy associated with aberrant IL-6 expression level.
Nakamura M; Iwamoto O; Chino T; Todoroki K; Kusukawa J
Diagn Pathol; 2016 May; 11(1):43. PubMed ID: 27142509
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
7. Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease.
Ogoshi T; Kido T; Yatera K; Oda K; Kawanami T; Ishimoto H; Sakamoto N; Sano A; Yoshii C; Shimajiri S; Mukae H
Lung; 2013 Dec; 191(6):575-83. PubMed ID: 23942842
[TBL] [Abstract][Full Text] [Related]
8. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.
Kinugawa Y; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Komatsu M; Yasuo M; Yamamoto H; Ota H
BMC Pulm Med; 2021 Jul; 21(1):219. PubMed ID: 34246246
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
10. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
11. A case of immunoglobulin G4-related respiratory disease with multiple lung cysts: A case report.
Mikumo H; Hamada N; Harada E; Yanagihara T; Ogata S; Yabuuchi H; Ijichi K; Takayama K; Nakanishi Y
Respir Med Case Rep; 2017; 21():89-92. PubMed ID: 28443233
[TBL] [Abstract][Full Text] [Related]
12. [Pathological significance of plasma cell infiltration in diagnosing lymph node diseases].
Hu H; Jiang YJ; Xu L; Yin LJ; Liu XF; Yin SY; Xu JJ; He MX
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):702-709. PubMed ID: 37408401
[No Abstract] [Full Text] [Related]
13. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
[TBL] [Abstract][Full Text] [Related]
14. IgG4-related Disease Involving Multiple Organs with Elevated Serum Interleukin-6 Levels.
Ikeura T; Horitani S; Masuda M; Kasai T; Yanagawa M; Miyoshi H; Uchida K; Takaoka M; Miyasaka C; Uemura Y; Okazaki K
Intern Med; 2016; 55(18):2623-8. PubMed ID: 27629957
[TBL] [Abstract][Full Text] [Related]
15. IgG4-Related Lymphadenopathy.
Sato Y; Yoshino T
Int J Rheumatol; 2012; 2012():572539. PubMed ID: 22719769
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
[TBL] [Abstract][Full Text] [Related]
17. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.
Takahashi H; Yamashita H; Morooka M; Kubota K; Takahashi Y; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2014 Jul; 81(4):331-6. PubMed ID: 24568886
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
[TBL] [Abstract][Full Text] [Related]
19. Comparison of plasma cell type of Castleman's disease and IgG4-related sclerosing disease: a histopathological and immunohistochemical study.
Jo JH; Park YS; Jeon YK; Nam SJ; Huh J
Pathobiology; 2011; 78(4):227-32. PubMed ID: 21778790
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT imaging features of patients with multicentric Castleman disease.
Jiang Y; Hou G; Zhu Z; Huo L; Li F; Cheng W
Nucl Med Commun; 2021 Jul; 42(7):833-838. PubMed ID: 33741858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
